HERMIONE: a randomized Phase 2 trial of MM-302 plus trastuzumab versus chemotherapy of physician’s choice plus trastuzumab in patients with previously treated, anthracycline-naïve, HER2-positive…

Overview of attention for article published in BMC Cancer, June 2016

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

twitter: 4 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 122 Dimensions

Readers on

mendeley: 215 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 7,784 followers.

Phase II Trial of MM-302 plus Trastuzumab vs Chemo plus Trastuzumab in Previously Treated Metastatic #BreastCancer https://t.co/qR4CHmrSC4

Reply Repost Favourite

RT @BibliotecaHUVH: HERMIONE: a randomized Phase 2 trial of MM-302 plus trastuzumab versus https://t.co/oHZWmaiADO #hvhebron #onco [Text co…

Reply Repost Favourite

HERMIONE: a randomized Phase 2 trial of MM-302 plus trastuzumab versus https://t.co/oHZWmaiADO #hvhebron #onco [Text complet] @BioMedCentral

Reply Repost Favourite

HERMIONE: a randomized Phase 2 trial of MM-302 plus trastuzumab versus chemotherapy of physician's… https://t.co/nS5xwJ1sOO #breastcancer

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.